ClinicalTrials.gg
CompletedNCT05290870Updated Jul 3, 2024

Registry Study on Intraocular Lenses Manufactured by Teleon Surgical B.V.

An observational study in Aphakia, Cataract and Clear Lens Exchange, sponsored by Teleon Surgical B.V.. Completed at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-03.

Sponsored by Teleon Surgical B.V. · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
2,183
Ages
18 Years and older
Sex
All
01

Study summary

This is a retrospective, observational (Registry) study aiming to collect safety and performance data on the use of intraocular lenses (IOLs) manufactured by Teleon Surgical B.V. according to routine practice.

02

Conditions studied

  • Aphakia
  • Cataract
  • Clear Lens Exchange
  • Refractive Lens Exchange

Browse trials for

Keywords

  • Pseudoaphakia
03

In context

Aphakia

69 studies on the registry are indexed under Aphakia; 6 are open to participants now.

This study's enrollment of 2,183 is above the median of 95 across 15 observational studies indexed under Aphakia.

Browse Aphakia studies →

Lead sponsor

Teleon Surgical B.V. is the lead sponsor of 3 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patients who have undergone uni- or bilateral extraction of the crystalline lens by means of phacoemulsification or femtosecond laser-assisted cataract surgery with implantation of the subject IOL.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients older than 18 years
  • Diagnosis of cataract in at least one eye or seeking clear/refractive lens exchange
  • Provide consent to retrospective data collection

Exclusion criteria

Exclusion Criteria:

  • Patients younger than 18 years
  • Patients with congenital primary aphakia or secondary aphakia
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
2,183 participants (actual)
Patient registry
No

Groups and cohorts

  • Subjects implanted with hydrophilic acrylic IOLs

    Subjects were implanted with a HydroSmart IOL (FEMTIS, LENTIS or VISIOTIS)

    Device: Posterior-chamber intraocular lens

  • Subjects implanted with hydrophobic acrylic IOLs

    Subjects were implanted with an ACUNEX IOL

    Device: Posterior-chamber intraocular lens

Interventions

  • DevicePosterior-chamber intraocular lens

    Implantation of a posterior-chamber intraocular lens to correct aphakia after removal of the crystalline lens

06

What researchers measure

Primary outcomes

  1. Visual acuity (uncorrected and/or corrected)

    Monocular visual acuity measured under photopic conditions from preoperative to Month 24 using standard methods (e.g. Snellen Chart 6/6-metre, 1.0 decimal or 0.0 logMAR) at standard distances (4 m for far, 65-80 cm for intermediate and 35-40 cm for near distance), depending on IOL optical design, as follows: For monofocal IOLs: • Uncorrected and corrected distance visual acuity For monofocal toric IOLs: * Uncorrected and corrected distance visual acuity * Residual astigmatism * IOL rotation For multifocal IOLs: * Uncorrected and corrected distance visual acuity * Uncorrected and corrected near visual acuity * Uncorrected and corrected intermediate visual acuity, if available For multifocal toric IOLs: * Uncorrected and corrected distance visual acuity * Uncorrected and corrected near visual acuity * Uncorrected and corrected intermediate visual acuity, if available * Residual astigmatism * IOL rotation

    Time frame: Preoperatively to Month 24

Secondary outcomes

  1. Adverse events and adverse device effects

    Time frame: Usual follow-up: 24 Months

  2. Patient and user satisfaction

    Satisfaction of the patient with the outcomes of the procedure/medical device Satisfaction of the user with handling of the medical device and patients outcomes

    Time frame: Month 1

07

Study locations

1 site
  • Teleon Surgical B.V.
    Spankeren, AV 6956, Netherlands
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 3, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05290870
Lead sponsor
Teleon Surgical B.V.
Collaborators
MaganaMed GmbH
Responsible party
Sponsor
First posted
Mar 22, 2022
Start date
Feb 1, 2022
Primary completion
Feb 29, 2024
Completion
Apr 30, 2024
Last update
Jul 3, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion